Eric A Osborn1, Farouc A Jaffer. 1. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02114, USA.
Abstract
PURPOSE OF REVIEW: Molecular imaging aims to illuminate vital molecular and cellular aspects of disease in vivo, and is rapidly translating into the clinical arena. Advantages of this field include enabling serial biological studies in living subjects, assessment of pharmaceutical efficacy, and in-vivo characterization of clinical diseases. Here we present recent exciting advances in molecular imaging of atherosclerotic vascular disease. RECENT FINDINGS: Atherosclerosis molecular imaging approaches are now available for magnetic resonance, nuclear, computed tomography, ultrasound, and near-infrared fluorescence imaging. Advances in agent synthesis and detection technology are now enabling in-vivo imaging of endothelial cell activation, macrophages, cellular metabolism, protease activity, apoptosis, and osteogenic activity. Several agents show clinical utility for the detection of high-risk plaques. SUMMARY: Molecular imaging is actively unraveling the biological basis of atherosclerosis in living subjects. In the near-term, molecular imaging will play an important role in assessing novel atherosclerosis pharmacotherapies in clinical trials. Longer term, molecular imaging should enable accurate identification of high-risk plaques responsible for myocardial infarction, stroke, and ischemic limbs.
PURPOSE OF REVIEW: Molecular imaging aims to illuminate vital molecular and cellular aspects of disease in vivo, and is rapidly translating into the clinical arena. Advantages of this field include enabling serial biological studies in living subjects, assessment of pharmaceutical efficacy, and in-vivo characterization of clinical diseases. Here we present recent exciting advances in molecular imaging of atherosclerotic vascular disease. RECENT FINDINGS:Atherosclerosis molecular imaging approaches are now available for magnetic resonance, nuclear, computed tomography, ultrasound, and near-infrared fluorescence imaging. Advances in agent synthesis and detection technology are now enabling in-vivo imaging of endothelial cell activation, macrophages, cellular metabolism, protease activity, apoptosis, and osteogenic activity. Several agents show clinical utility for the detection of high-risk plaques. SUMMARY: Molecular imaging is actively unraveling the biological basis of atherosclerosis in living subjects. In the near-term, molecular imaging will play an important role in assessing novel atherosclerosis pharmacotherapies in clinical trials. Longer term, molecular imaging should enable accurate identification of high-risk plaques responsible for myocardial infarction, stroke, and ischemic limbs.
Authors: Bas L J H Kietselaer; Chris P M Reutelingsperger; Guido A K Heidendal; Mat J A P Daemen; Werner H Mess; Leonard Hofstra; Jagat Narula Journal: N Engl J Med Date: 2004-04-01 Impact factor: 91.245
Authors: Samuel A Wickline; Anne M Neubauer; Patrick Winter; Shelton Caruthers; Gregory Lanza Journal: Arterioscler Thromb Vasc Biol Date: 2005-12-22 Impact factor: 8.311
Authors: M E Kooi; V C Cappendijk; K B J M Cleutjens; A G H Kessels; P J E H M Kitslaar; M Borgers; P M Frederik; M J A P Daemen; J M A van Engelshoven Journal: Circulation Date: 2003-04-28 Impact factor: 29.690
Authors: Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson Journal: Circulation Date: 2003-10-14 Impact factor: 29.690
Authors: Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson Journal: Circulation Date: 2003-10-07 Impact factor: 29.690
Authors: Rikin A Trivedi; Jean-Marie U-King-Im; Martin J Graves; Justin J Cross; Jo Horsley; Martin J Goddard; Jeremy N Skepper; George Quartey; Elizabeth Warburton; Ilse Joubert; Liqun Wang; Peter J Kirkpatrick; John Brown; Jonathan H Gillard Journal: Stroke Date: 2004-05-27 Impact factor: 7.914
Authors: J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg Journal: Circulation Date: 2002-06-11 Impact factor: 29.690
Authors: Masahiro Terashima; Masaki Uchida; Hisanori Kosuge; Philip S Tsao; Mark J Young; Steven M Conolly; Trevor Douglas; Michael V McConnell Journal: Biomaterials Date: 2010-11-11 Impact factor: 12.479
Authors: Zhonglin Liu; Brandon T Larsen; Lilach O Lerman; Brian D Gray; Christy Barber; Ahmad F Hedayat; Ming Zhao; Lars R Furenlid; Koon Y Pak; James M Woolfenden Journal: Nucl Med Biol Date: 2016-05-19 Impact factor: 2.408
Authors: Chuqiao Tu; Thomas S C Ng; Hargun K Sohi; Heather A Palko; Adrian House; Russell E Jacobs; Angelique Y Louie Journal: Biomaterials Date: 2011-07-13 Impact factor: 12.479
Authors: Peter Caravan; Ilknur Ay; David Izquierdo-Garcia; Himashinie Diyabalanage; Ian A Ramsay; Nicholas J Rotile; Adam Mauskapf; Ji-Kyung Choi; Thomas Witzel; Valerie Humblet; Farouc A Jaffer; Anna-Liisa Brownell; Ahmed Tawakol; Ciprian Catana; Mark F Conrad Journal: Stroke Date: 2021-12-30 Impact factor: 7.914
Authors: Marcin Woźniak; Christian J Konopka; Agata Płoska; Jamila Hedhli; Anna Siekierzycka; Maciej Banach; Rafal Bartoszewski; Lawrence W Dobrucki; Leszek Kalinowski; Iwona T Dobrucki Journal: Cell Mol Biol Lett Date: 2021-03-16 Impact factor: 5.787